We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

SEBIA

Sebia provides clinical protein electrophoresis equipment and reagents for in-vitro diagnostic testing, including sys... read more Featured Products: More products

Download Mobile App




Capillary Electrophoresis Evaluated for Hemoglobinopathy Testing

By LabMedica International staff writers
Posted on 25 May 2015
Print article
The Minicap Flex Piercing capillary zone electrophoresis system
The Minicap Flex Piercing capillary zone electrophoresis system (Photo courtesy of SEBIA)
The detection of structural hemoglobin (Hb) variants and thalassemia has become increasingly important in clinical laboratories of all countries with a large influx of immigrants over the past 10 years.

Guidelines for hemoglobinopathy screening not only recommend the use of quantitative techniques for thalassemia detection, they also stress the use of a confirmatory method when an Hb variant is detected. In an ideal setting, both techniques can be met by a combination of high-performance liquid chromatography (HPLC) and capillary zone electrophoresis (CZE).

Scientists at the University Hospital Leuven (Belgium) and their colleagues evaluated a suitable stand-alone method for hemoglobinopathy screening of approximately 50 clinical samples a week. The studied the analytical performance of a CZE and set up a comparison with two well-established HPLC methods.

Capillary zone electrophoresis was performed using the Minicap Flex Piercing CZE system (Sebia; Norcross, GA, USA). The instrument is equipped to resuspend, lyse, separate, and analyze whole blood samples for variants collected in ethylenediaminetetraacetic acid (EDTA) tubes. The lysed red cells are electrophoresed in alkaline buffer (pH 9.4) allowing separation to be directed by pH and endosmosis. Detection of eluting hemoglobin species is accomplished using the change in absorbance at 415 nm. CZE does not require daily calibration, but normal HbA and HbA2 migration controls are analyzed daily through each capillary before additional quality control (QC), or patient samples are run to ensure proper charge and function of both capillaries. The two well-established HPLC methods were the Bio-Rad Variant Classic and the Bio-Rad D-10 instruments (Bio-Rad Laboratories; Hercules, CA, USA).

The analytical performance was acceptable for the determination of HbA, HbA2, HbS, and HbF, with an imprecision equal to or less than 2.0%. Method comparison showed a linear correlation for HbA2, HbF, and HbS measurements. Clinical concordance was acceptable when comparing CZE and HPLC. Hb variant presumptive identification was evaluated by analyzing seven samples with confirmed heterogeneous or homogeneous presence of Hb variants: two HbC, one HbD, one HbE and HbA2'. One sample was compound heterogeneous for HbS and HbC. On the Minicap Flex Piercing, a minimal overlap between HbC and HbA2 was found.

The authors concluded that as HPLC methods have the advantage of a great precision in detection of a large number of variants, it has the disadvantage of a complex elution pattern that may be difficult to interpret for many routine chemistry laboratories. The Minicap Flex Piercing showed similar analytical performance compared to previous published work using CZE. As for HPLC, CZE gives only a provisional identification of variant hemoglobins, and confirmation by an alternative method based on a different principle is needed. The study was published in the June 2015 issue of the International Journal of Laboratory Hematology.

Related Links:

University Hospital Leuven
Sebia 
Bio-Rad Laboratories 


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Gold Member
Chagas Disease Test
CHAGAS Cassette
New
Dehydroepiandrosterone Assay
DHEA ELISA
New
RFID Tag
AD-302 M730
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A coronal MRI section shows a high-intensity focused ultrasound lesion in the left thalamus of the brain (Photo courtesy of UT Southwestern Medical Center)

Newly Identified Stroke Biomarkers Pave Way for Blood Tests to Quickly Diagnose Brain Injuries

Each year, nearly 800,000 individuals in the U.S. experience a stroke, which occurs when blood flow to specific areas of the brain is insufficient, causing brain cells to die due to a lack of oxygen.... Read more

Immunology

view channel
Image: The discovery of biomarkers could improve endometrial cancer treatment (Photo courtesy of Mount Sinai)

Simple Blood Test Could Help Choose Better Treatments for Patients with Recurrent Endometrial Cancer

Endometrial cancer, which develops in the lining of the uterus, is the most prevalent gynecologic cancer in the United States, affecting over 66,000 women annually. Projections indicate that in 2025, around... Read more

Pathology

view channel
Image: As tumor cells flow through these microfluidic chambers, they are subjected to increasing shear stress and sorted based on their adhesion strength (Photo courtesy of UC San Diego)

Microfluidic Device Assesses Stickiness of Tumor Cells to Predict Cancer Spread

Ductal carcinoma in situ (DCIS), a type of early-stage breast cancer, is often referred to as stage zero breast cancer. In many cases, it remains harmless and does not spread beyond the milk ducts where... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.